Trial of DB289 for the Treatment of Stage I African Trypanosomiasis

NCT00803933 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

111

Enrollment

INDUSTRY

Sponsor class

Conditions

African Trypanosomiasis

Interventions

DRUG: DB289
DRUG: Pentamidine

Sponsor

Immtech Pharmaceuticals, Inc

Collaborators

[object Object]